Valor Equity Partners
Valor Equity Partners is a Chicago-based growth investor that provides hands-on operational expertise to help growth companies scale across the United States. The firm partners with management teams to accelerate growth and transform markets through investments in technology and technology-enabled businesses, as well as consumer products, engineered products, and services. It supports early-stage, expansion-stage, and growth-stage companies with substantial capital to drive rapid growth, often targeting software, SaaS, manufacturing, and other high-growth sectors. Valor emphasizes long-term partnerships, disciplined performance improvement, and strategic transformations to help portfolio companies achieve sustainable competitive advantage in North America.
Top Stages
https://crunchbase.com/organization/***
https://linkedin.com/company/***
Past deals in Pets
Loyal
Series B in 2025
Loyal is a biotechnology company focused on developing medicines to extend the lifespan of dogs. By creating drugs that potentially slow aging processes, they aim to delay or prevent age-related diseases such as cancer and dementia.
Loyal
Series B in 2024
Loyal is a biotechnology company focused on developing medicines to extend the lifespan of dogs. By creating drugs that potentially slow aging processes, they aim to delay or prevent age-related diseases such as cancer and dementia.
Spot & Tango
Series A in 2022
Spot & Tango is a New York City-based manufacturer of human-grade dog food that focuses on delivering high-quality health and wellness products directly to consumers. The company specializes in fresh, nutritious, and sustainable dog food, developed by a team of leading animal nutritionists. Spot & Tango offers personalized meal plans tailored to each dog's weight, activity level, and lifestyle, ensuring that pet owners can provide their pets with optimal nutrition. Their products are accessible online and in pet specialty stores, and they emphasize eco-friendly packaging for their deliveries.
Spot & Tango
Series B in 2022
Spot & Tango is a New York City-based manufacturer of human-grade dog food that focuses on delivering high-quality health and wellness products directly to consumers. The company specializes in fresh, nutritious, and sustainable dog food, developed by a team of leading animal nutritionists. Spot & Tango offers personalized meal plans tailored to each dog's weight, activity level, and lifestyle, ensuring that pet owners can provide their pets with optimal nutrition. Their products are accessible online and in pet specialty stores, and they emphasize eco-friendly packaging for their deliveries.
PetDx
Series B in 2021
PetDx is a San Diego-based molecular diagnostics company that specializes in the early detection of cancer in pets through innovative liquid biopsy technology. The company's main product, OncoK9, is a first-in-class multi-cancer early detection test that allows veterinarians to identify cancer in dogs using a simple blood draw. By utilizing advanced genomic analysis, including next-generation sequencing and proprietary bioinformatics algorithms, PetDx empowers veterinarians to enhance the care they provide to canine patients. The company's focus on non-invasive testing and customized assays positions it at the forefront of veterinary oncology, aiming to revolutionize how cancer is detected, characterized, and managed in pets.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.